Akhila Wimalasingham
Impact in
-
- Renal cell carcinoma treatment
-
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
Papers in
-
- Renal cell carcinoma treatment 3
- Advanced Breast Cancer Therapies 2
- Ferroptosis and cancer prognosis 1
- Surgery 5
- Bladder and Urothelial Cancer Treatments 5
- Co-authors
- Bernadett Szabados (4 shared papers)Thomas Powles (2 shared papers)Simon Chowdhury (2 shared papers)Yen Zhi Tang (2 shared papers)Nick van Dijk (1 shared paper)Mark Linch (1 shared paper)Thomas Powles (4 shared papers)Michiel S. van der Heijden (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)European Urology (2 papers)Bladder Cancer (1 paper)Cancer Research (1 paper)Cancer Medicine (1 paper)
- Partner nations
- United KingdomGermanyUnited States
In The Last Decade
Akhila Wimalasingham
9 papers receiving 214 citations
Peers
Comparison fields: 5 of 34
- Pulmonary and Respiratory Medicine 74
- Cancer Research 33
- Oncology 53
- Otorhinolaryngology 7
- Surgery 62
Countries citing papers authored by Akhila Wimalasingham
This map shows the geographic impact of Akhila Wimalasingham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akhila Wimalasingham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akhila Wimalasingham more than expected).
Fields of papers citing papers by Akhila Wimalasingham
This network shows the impact of papers produced by Akhila Wimalasingham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akhila Wimalasingham. The network helps show where Akhila Wimalasingham may publish in the future.
Co-authors
The 25 scholars most cited alongside Akhila Wimalasingham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 86 | |
| 2 | 2017 | 72 | |
| 3 | 2020 | 22 | |
| 4 | 2021 | 15 | |
| 5 | 2016 | 12 | |
| 6 | 2016 | 5 | |
| 7 | 2017 | 2 | |
| 8 | 2021 | 1 | |
| 9 | 2021 | 1 | |
| 10 | 2017 | 0 |
About Akhila Wimalasingham
Akhila Wimalasingham is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Oncology, Epidemiology and Urology, having authored 10 papers that have together received 216 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Renal cell carcinoma treatment (3 papers), Multiple and Secondary Primary Cancers (2 papers), Advanced Breast Cancer Therapies (2 papers), Cancer Research and Treatments (1 paper), Lung Cancer Research Studies (1 paper) and Ferroptosis and cancer prognosis (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (74 citations), Cancer Research (33 citations), Oncology (53 citations), Otorhinolaryngology (7 citations) and Surgery (62 citations). Akhila Wimalasingham has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include Bernadett Szabados, Thomas Powles, Simon Chowdhury, Yen Zhi Tang, Nick van Dijk, Mark Linch, Thomas Powles, Michiel S. van der Heijden, Sarah Rudman and Simon Hughes. Their work appears in journals such as Journal of Clinical Oncology, European Urology, Bladder Cancer, Cancer Research and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.